Literature DB >> 17068983

Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample.

Anjali A Patwardhan1, Martin G Larson, Daniel Levy, Emelia J Benjamin, Eric P Leip, Michelle J Keyes, Thomas J Wang, Daniel J Gottlieb, Ramachandran S Vasan.   

Abstract

STUDY
OBJECTIVES: We hypothesized that alterations in cardiac hemodynamics associated with obstructive sleep apnea-hypopnea (OSAH) would be reflected in higher natriuretic peptide levels. We examined the association of OSAH with natriuretic peptides in a community-based sample.
DESIGN: Cross-sectional, retrospective, observational study.
SETTING: Framingham Heart Study Offspring Cohort and Sleep Heart Health Study. PARTICIPANTS: Community-based sample of 623 individuals. MEASUREMENTS: Full-montage home polysomnography was used to determine apnea-hypopnea index (AHI) and percentage of time with an oxyhemoglobin saturation < 90% (PctLt90). Sensitive immunoradiometric assays were used to measure plasma B-type (BNP) and N-terminal pro-atrial natriuretic peptide (NT-ANP). Multivariable regression was used to examine the relations between natriuretic peptides and indicators of OSAH, adjusting for age, sex, body mass index, and clinical covariates.
RESULTS: No statistically significant relations between OSAH indices and BNP were observed in the multivariable model. Compared with an AHI < 5, relative levels of 1.20, 0.88, and 0.91 were observed forAHI categories 5-15, 15-30, >30 events per hour, respectively. For NT-ANP, no significant relations were seen with AHI in the multivariable model (relative levels of 0.98, 0.91, and 0.90). An inverse association was observed between NT-ANP and PctLt90 in age- and sex-adjusted models (relative levels of 0.93, 0.87, and 0.80), although this association became statistically nonsignificant after adjusting for body mass index.
CONCLUSION: Lack of association of natriuretic peptides with OSAH indices suggests that undiagnosed OSAH may not be associated with major alterations in left ventricular function, as reflected in morning natriuretic peptide levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068983     DOI: 10.1093/sleep/29.10.1301

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  19 in total

1.  Development of the National Healthy Sleep Awareness Project Sleep Health Surveillance Questions.

Authors:  Timothy I Morgenthaler; Janet B Croft; Leslie C Dort; Lauren D Loeding; Janet M Mullington; Sherene M Thomas
Journal:  J Clin Sleep Med       Date:  2015-09-15       Impact factor: 4.062

Review 2.  Biomarkers in Sleep Apnea and Heart Failure.

Authors:  Ying Y Zhao; Reena Mehra
Journal:  Curr Heart Fail Rep       Date:  2017-08

Review 3.  Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility.

Authors:  M Melanie Lyons; Nitin Y Bhatt; Elizabeth Kneeland-Szanto; Brendan T Keenan; Joanne Pechar; Branden Stearns; Nabil M Elkassabany; Stavros G Memtsoudis; Allan I Pack; Indira Gurubhagavatula
Journal:  Biomark Med       Date:  2016       Impact factor: 2.851

4.  Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study.

Authors:  Gabriela Querejeta Roca; Susan Redline; Naresh Punjabi; Brian Claggett; Christie M Ballantyne; Scott D Solomon; Amil M Shah
Journal:  Am J Respir Crit Care Med       Date:  2013-12-15       Impact factor: 21.405

5.  The Clinical Value of N-Terminal Pro B-Type Natriuretic Peptide in Evaluating Obstructive Sleep Apnea in Patients With Coronary Artery Disease.

Authors:  Yuanhui Liu; Zhihua Huang; Kaizhuang Huang; Guang Li; Jianfang Luo; Ying Xu; Pingyan Chen; Jiyan Chen; Ling Wang
Journal:  J Clin Sleep Med       Date:  2019-10-15       Impact factor: 4.062

Review 6.  What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea?

Authors:  Ivan Guerra de Araújo Freitas; Pedro Felipe Carvalhedo de Bruin; Lia Bittencourt; Veralice Meireles Sales de Bruin; Sérgio Tufik
Journal:  Sleep Breath       Date:  2015-02-26       Impact factor: 2.816

Review 7.  Mechanisms of cardiac dysfunction in obstructive sleep apnea.

Authors:  Jean-Philippe Baguet; Gilles Barone-Rochette; Renaud Tamisier; Patrick Levy; Jean-Louis Pépin
Journal:  Nat Rev Cardiol       Date:  2012-09-25       Impact factor: 32.419

8.  N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea.

Authors:  Micha T Maeder; Peter Ammann; Hans Rickli; Otto D Schoch; Wolfgang Korte; Christoph Hürny; Jonathan Myers; Thomas Münzer
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

9.  Sleep apnea: An overlooked cause of lipotoxicity?

Authors:  Chenjuan Gu; Haris Younas; Jonathan C Jun
Journal:  Med Hypotheses       Date:  2017-09-13       Impact factor: 1.538

10.  Association between obstructive sleep apnea and elevated levels of type B natriuretic peptide in a community-based sample of women.

Authors:  Mirjam Ljunggren; Bertil Lindahl; Jenny Theorell-Haglöw; Eva Lindberg
Journal:  Sleep       Date:  2012-11-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.